Evidence map›Paper›PMID 30988409›Full record

ArticleJournal of human genetics2019

Translocation breakpoint disrupting the host SNHG14 gene but not coding genes or snoRNAs in typical Prader-Willi syndrome.

Ming Lei, Satomi Mitsuhashi, Noriko Miyake, Tohru Ohta, Desheng Liang, Lingqian Wu, Naomichi Matsumoto

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. A Transcriptomic Signature of Depressive Symptoms in Late Life.Biological psychiatry global open science · 2025
    Article
  2. UsingRNA biology · 2023
    Article
  3. Review
  4. Analysis ofGenes · 2022
    Review
  5. A NovelJournal of pediatric genetics · 2022
    Article
  6. Review
  7. Molecular medicine reports · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ming LeiCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.
Satomi MitsuhashiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Fukuura 3-9, Kanazawa-ku, Yokohama, 236-0004, Japan.
Noriko MiyakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Fukuura 3-9, Kanazawa-ku, Yokohama, 236-0004, Japan.
Tohru OhtaInstitute of Health Science, Health Science University of Hokkaido, Hokkaido, Japan.
Desheng LiangCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.
Lingqian WuCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, China. wulingqian@sklmg.edu.cn.ORCID http://orcid.org/0000-0002-7070-5896
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Fukuura 3-9, Kanazawa-ku, Yokohama, 236-0004, Japan. naomat@yokohama-cu.ac.jp.
Central South University · CNYokohama City University · JPHealth Sciences University of Hokkaido · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP18dm0107090Japan Agency for Medical Research and Development (AMED) JP18ek0109280Japan Agency for Medical Research and Development (AMED) JP18ek0109301Japan Agency for Medical Research and Development (AMED) JP18ek0109348Japan Agency for Medical Research and Development (AMED) JP18kk020500MEXT | Japan Society for the Promotion of Science (JSPS) JP16H05357MEXT | Japan Society for the Promotion of Science (JSPS) JP17H01539MEXT | Japan Society for the Promotion of Science (JSPS) JP17K16132National Natural Science Foundation of China (National Science Foundation of China) 31601035National Natural Science Foundation of China (National Science Foundation of China) 81771599
6 · The paper itself

Abstract

Prader-Willi syndrome (PWS) is a well-known imprinting disorder arising from a loss of paternally imprinted gene(s) at 15q11.2-q13. We report a typical PWS patient with a balanced reciprocal translocation, 46, XY, t(15;19)(q11.2;q13.3). After Illumina whole-genome sequencing, we used BreakDancer-1.45 software to predict candidate breakpoints and manually investigated via the Integrated Genome Viewer. Breakpoint PCR followed by Sanger sequencing determined the t(15;19) breakpoints. We investigated the expression of upstream/centromeric and downstream/telomeric genes of the 15q11.2 breakpoint by reverse transcriptase PCR, using total RNA extracted from the patient's lymphoblasts. Of note, the expression of paternally expressed genes PWAR6, SNORD109A/B, SNORD116, IPW, and PWAR1, downstream of the breakpoint, was abolished. Interestingly, the breakpoint did not destroy protein coding genes or individual snoRNAs. These results indicate that these genes may play a major role in the PWS phenotype.

Indexed as

Translocation, GeneticAdolescentChromosome BreakpointsChromosomes, Human, Pair 15Chromosomes, Human, Pair 19Genomic ImprintingHumansMalePhenotypePrader-Willi SyndromeRNA, Long NoncodingRNA, Small NucleolarWhole Genome SequencingRNA, Long NoncodingRNA, Small NucleolarSNORD116 RNA, human

Identifiers

PMID30988409
OpenAlexW2939768468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.